Daniel Blockmans
Overview
Explore the profile of Daniel Blockmans including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
144
Citations
3511
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Blockmans D, Moreel L, Betrains A, Vanderschueren S, Coudyzer W, Boeckxstaens L, et al.
Front Med (Lausanne)
. 2024 Apr;
11:1384533.
PMID: 38572159
Background: A positive PET scan at diagnosis was associated with a greater yearly increase in ascending and descending aortic diameter and thoracic aortic volume in patients with giant cell arteritis...
12.
Moreel L, Boeckxstaens L, Betrains A, Smans T, Molenberghs G, Van Laere K, et al.
Rheumatology (Oxford)
. 2024 Mar;
63(12):3331-3336.
PMID: 38547403
Objectives: Two recent meta-analyses reported subclinical vasculitis in 22-23% of patients with PMR. We aimed to evaluate the prevalence, characteristics, and outcome of subclinical vasculitis among our PMR patients. Methods:...
13.
Moreel L, Betrains A, Molenberghs G, Vanderschueren S, Blockmans D
Joint Bone Spine
. 2024 Mar;
91(3):105706.
PMID: 38458850
No abstract available.
14.
Betrains A, Moreel L, Mulders-Manders C, Auwaerter P, Torne-Cachot J, Weitzer F, et al.
Eur J Intern Med
. 2024 Mar;
124:115-121.
PMID: 38431500
Background: Patients with inflammation of unknown origin (IUO) and fever of unknown origin (FUO) are commonly considered a single population. Differences in underlying causes between both groups may steer the...
15.
Stone J, Han J, Aringer M, Blockmans D, Brouwer E, Cid M, et al.
Lancet Rheumatol
. 2024 Jan;
3(5):e328-e336.
PMID: 38279390
Background: The combination of tocilizumab plus a glucocorticoid taper is effective in maintaining clinical remission without requiring additional glucocorticoid therapy in patients with giant cell arteritis, as shown in part...
16.
Keller K, Mukhtyar C, Nielsen A, Hemmig A, Mackie S, Sattui S, et al.
Ann Rheum Dis
. 2023 Dec;
83(11):1436-1442.
PMID: 38050004
Objective: To develop international consensus-based recommendations for early referral of individuals with suspected polymyalgia rheumatica (PMR). Methods: A task force including 29 rheumatologists/internists, 4 general practitioners, 4 patients and a...
17.
Moreel L, Coudyzer W, Boeckxstaens L, Betrains A, Molenberghs G, Vanderschueren S, et al.
Ann Intern Med
. 2023 Oct;
176(10):1321-1329.
PMID: 37782924
Background: Previous studies have shown that patients with giant cell arteritis (GCA) who have vascular F-fluorodeoxyglucose (FDG) uptake at diagnosis are at increased risk for thoracic aortic complications. Objective: To...
18.
Dejaco C, Ramiro S, Bond M, Bosch P, Ponte C, Mackie S, et al.
Ann Rheum Dis
. 2023 Aug;
83(6):741-751.
PMID: 37550004
Objectives: To update the EULAR recommendations for the use of imaging modalities in primary large vessel vasculitis (LVV). Methods: A systematic literature review update was performed to retrieve new evidence...
19.
Vulsteke J, Smith V, Bonroy C, Lenaerts J, Derua R, Wuyts W, et al.
J Autoimmun
. 2023 Jun;
139:103056.
PMID: 37302272
ObjectiveMultiple spliceosome components are known autoantigens in systemic sclerosis (SSc). Here we aim to identify new and characterize rare anti-spliceosomal autoantibodies in patients with SSc without known autoantibody specificity. MethodsSera...
20.
Betrains A, Moreel L, Wright W, Blockmans D, Vanderschueren S
Intern Emerg Med
. 2023 May;
18(6):1865-1869.
PMID: 37191773
No abstract available.